Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | SCN4A | P35499 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | SCN1A | P35498 | 2/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558466 | 0.85 | TRPA1 (0.50) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL19979060 | 0.84 | ALDH1A1 (0.37) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL22728357 | 0.84 | ACHE (0.46) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL8973695 | 0.84 | CD44 (0.48) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL6745083 | 0.84 | ALDH1A1 (0.46) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL24481223 | 0.80 | GABRA1 (0.45) | ALDH1A1TSHRSCN4ALMNACYP3A4 | |
| SCHEMBL8932197 | 0.80 | ALDH1A1 (0.48) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL12238610 | 0.79 | CA1 (0.42) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL23364851 | 0.79 | IRAK4 (0.41) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL29932941 | 0.79 | IRAK4 (0.41) | CA1CA2CA7CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111141849-B | Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material | 江苏开元药业有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-113325096-B | Detection method of 1- (2,3-dimethylphenyl) ethanol related substances | 石家庄四药有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-113325096-A | Detection method of 1- (2, 3-dimethylphenyl) ethanol related substances | 石家庄四药有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-111141849-A | Liquid phase detection and separation method for positional isomer of dexmedetomidine starting material | 江苏开元药业有限公司 | 2020-05-12 | — | — | CN | claimed |
| US-20260000642-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | TAY THERAPEUTICS LTD (GB) | 2026-01-01 | — | — | US | disclosed |
| US-20250263370-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | Tay Therapeutics Limited (GB) | 2025-08-21 | — | — | US | disclosed |
| EP-4558224-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | Tay Therapeutics Limited (GB) | 2025-05-28 | — | — | EP | disclosed |
| CN-118978425-A | Process for preparing substituted 2-aryl ethanol | 拜耳作物科学股份公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-108473402-B | Process for preparing substituted 2-aryl ethanol | 拜耳作物科学股份公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2024018423-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | Tay Therapeutics Limited (GB) | 2024-01-25 | — | — | WO | disclosed |
| CN-111141849-B | Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material | 江苏开元药业有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-113325096-B | Detection method of 1- (2,3-dimethylphenyl) ethanol related substances | 石家庄四药有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-20030064991-A1 | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor | MILLENNIUM PHARMACEUTICALS, INC. | 2003-04-03 | — | — | US | disclosed |
| WO-2002072549-A1 | FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| CN-1344270-A | Functionalized heterocycles as chemokine receptor modulators | THOUSAND YEARS MEDICAMENTS INC (US) | 2002-04-10 | — | — | CN | disclosed |
| EP-1144415-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000042045-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| US-4742073-A | ANTIGLAUCOMA | BUNDGAARD HANS (DK) | 1988-05-03 | — | — | US | disclosed |
| EP-0149976-A2 | Substituted imidazoles | CIBA-GEIGY AG (CH) | 1985-07-31 | — | — | EP | disclosed |
| EP-0106541-A2 | Pilocarpine prodrugs | Bundgaard, Hans (DK) | 1984-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064991-A1 | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor | ACKR3, CCR5, CXCR4 | CA1 3029/4885CA2 3312/4885CA7 2839/4885 |
| US-20260000642-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | BET1, BRD4, PHKB | CA1 4153/4885CA2 915/4885CA7 3370/4885 |
| US-20250263370-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | BET1, PHKB, BRD4 | CA1 4585/4885CA2 3704/4885CA7 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.